(Q34336818)

1 August 2017

title

Diagnosis and treatment of sarcoma of the uterus. A review (English)

1 reference

1 August 2017

1

Claes G Tropé

1 reference

1 August 2017

Vera M Abeler

2

1 reference

1 August 2017

Gunnar B Kristensen

series ordinal

3

1 reference

1 August 2017

publication date

1 July 2012

1 reference

1 August 2017

1 reference

1 August 2017

volume

51

1 reference

1 August 2017

issue

6

1 reference

1 August 2017

page(s)

694-705

1 reference

Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Uterine sarcomas: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: An analysis of 26,758 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

A new system for grading recommendations in evidence based guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

START: a European state-of-the-art on-line instrument for clinical oncologists.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

A systematic overview of chemotherapy effects in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Uterine sarcomas in Norway 1956-1992: incidence, survival and mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Mechanisms of sarcoma development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Molecular analysis of the JAZF1-JJAZ1 gene fusion by RT-PCR and fluorescence in situ hybridization in endometrial stromal neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Postirradiation sarcoma of the gynecologic tract. A report of 13 cases and a discussion of the risk of radiation-induced gynecologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

The WHO Collaborative Study of Neoplasia and Steroid Contraceptives: the influence of combined oral contraceptives on risk of neoplasms in developing and developed countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Uterine sarcoma associated with tamoxifen use.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Association of tamoxifen and uterine sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Imaging of female pelvic malignancies regarding MRI, CT, and PET/CT : part 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Positron emission tomography with (18)F-fluorodeoxyglucose of uterine sarcoma: a comparison with magnetic resonance imaging and power Doppler imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Surgical treatment of uterine sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Leiomyosarcoma (LMS) and endometrial stromal sarcoma (ESS) of the uterus. A survey of patients treated in the Norwegian Radium Hospital 1976-1985.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Endometrial stromal sarcoma: a population-based analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Ploidy in gynaecological cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

The Use of p16 in enhancing the histologic classification of uterine smooth muscle tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

The expression of Ki-67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas. A clinicopathologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

ERBB-2 gene overexpression and amplification in uterine sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Immunohistochemical determination of estrogen and progesterone receptor positivity in uterine adenosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Uterine leiomyosarcoma: does the primary surgical procedure matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Management of uterine malignancy found incidentally after supracervical hysterectomy or uterine morcellation for presumed benign disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Prognostic factors and treatment outcomes of patients with uterine sarcoma: analysis of 127 patients at a single institution, 1989-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

The impact of tumor morcellation during surgery on the outcomes of patients with apparently early low-grade endometrial stromal sarcoma of the uterus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Clinical study investigating the role of lymphadenectomy, surgical castration and adjuvant hormonal treatment in endometrial stromal sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Ovarian preservation in stage I low-grade endometrial stromal sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Lymphadenectomy and ovarian preservation in low-grade endometrial stromal sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Staging of uterine sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Secondary cytoreduction in the management of recurrent uterine leiomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

The Changing Role of Surgery for Pulmonary Metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Results of a single-center experience with resection and ablation for sarcoma metastatic to the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Uterine sarcoma: twenty-seven years of experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Results of postoperative radiotherapy in the treatment of sarcoma of the corpus uteri.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Uterine Neoplasms. Clinical Practice Guidelines in Oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Phase II evaluation of liposomal doxorubicin (Doxil) in recurrent or advanced leiomyosarcoma of the uterus: a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Long-term survival of patients given hormonal therapy for metastatic endometrial stromal sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Metastatic uterine leiomyosarcoma regression using an aromatase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

Validation of tumor size as staging variable in the revised International Federation of Gynecology and Obstetrics stage I leiomyosarcoma: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.689111

10.3109/0284186X.2012.689111

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference